Manufacturing
Counterfeit Parts and Suspect Components
In one line
Risk of unauthorized, fraudulent, or substandard components entering the supply chain.
Definition
Counterfeit electronic components and substandard materials have caused field failures and recalls in MedTech. Mitigation includes authorized-distributor sourcing, incoming inspection, and AS6081/AS6171-style detection methods for electronics.
Risk is highest during component shortages, when buyers turn to brokers. Controls include requiring certificates of conformance, testing samples for authenticity, and quarantining suspect parts. SAE AS5553 covers counterfeit avoidance for electronic parts. Suspect parts found after use should be assessed through CAPA and, where needed, field action decisions.
Why it matters
Heightened concern after EUA-era ventilator and respirator supply chains exposed widespread component fraud.
Common pitfalls
- •A common pitfall is relying solely on price as a purchasing criterion, which can inadvertently lead to the acquisition of counterfeit or substandard components.
- •Another mistake is neglecting to conduct regular audits of suppliers and their quality systems, missing early indicators of potential supply chain vulnerabilities.
- •Failing to implement a robust incoming inspection process risks integrating non-conforming components directly into medical devices, jeopardizing patient safety and device effectiveness.
- •Misinterpreting “authorized distributor” as a blanket guarantee of authenticity without verifying the distributor’s specific authorization for the purchased components is a common misconception.
- •Overlooking the need for specialized training for personnel involved in component procurement and inspection can lead to inadequate identification of suspect parts.
Sources
- SAE AS6081 · SAE
- FDA - Device Manufacturing · FDA
- ISO 13485 Standard Page · ISO